FrancophonIA/ELRC3.0 huggingface dataset:
English: g Figures presented are cumulative percentages based upon a Kaplan Meier analysis including data collected after the addition of emtricitabine to open-label tenofovir disoproxil (KM-ITT).
Danish: De viste tal er kumulative procentdele baseret på en Kaplan Meier-analyse, som inkluderer data indsamlet efter tillæg af emtricitabin til open-label tenofovirdisoproxil (KM-ITT).
English: + Raltegravir (400 mg b.i.d) + Emtricitabine/Tenofovir disoproxil (200 mg/245 mg q.d.)
Danish: + Raltegravir (400 mg b.i.d) + Emtricitabin/tenofovirdisoprox il (200 mg/245 mg q.d.)
English: 11l a Based upon Long Term Evaluation algorithm (LTE Analysis) - Patients who discontinued the study at any time prior to week 384
Danish: Tab af HBsAg/ serokonversion n k n n a Baseret på Long Term Evaluation algoritme (LTE-analyse) - Patienter, som afbrød studiet på et vilkårligt tidspunkt før uge 384 pga. et protokoldefineret endepunkt, såvel som dem, der fuldførte uge 384, inkluderes i nævneren.
English: - decompensated liver disease (see sections 4.4, 4.8 and 5.1).
Danish: 4.4, 4.8 og 5.1).
English: NRTIs Didanosine
Danish: NRTIer Didanosin
English: The following side effects are very common (may affect more than 1 in 10 people):
Danish: Følgende bivirkninger er meget almindelige (kan opstå hos mere end 1 ud af 10 personer):
English: 245 mg and stavudine groups, respectively).
Danish: 245 mg tenofovirdisoproxil og stavudin gruppen).
English: l Figures presented are cumulative percentages based upon a Kaplan Meier analysis excluding data collected after the addition of emtricitabine to open-label tenofovir disoproxil (KM-tenofovir disoproxil).
Danish: De viste tal er kumulative procenter baseret på en Kaplan Meier-analyse, som ekskluderer data indsamlet efter tillæg af emtricitabin til open-label tenofovirdisoproxil (KM-tenofovirdisoproxil).
English: No amino acid substitutions associated with tenofovir disoproxil resistance were detected in any subject.
Danish: Der blev ikke identificeret aminosyresubstitutioner forbundet med tenofovirdisoproxil-resistens hos nogen forsøgspersoner.
English: - Tenofovir disoproxil Zentiva should not be administered concomitantly with adefovir dipivoxil.
Danish: - Tenofovir disoproxil Zentiva bør ikke tages samtidigt med adefovirdipivoxil.
English: headache
Danish: hovedpine
English: n Figures presented are cumulative percentages based upon a Kaplan Meier analysis excluding data collected after the addition of emtricitabine to open-label tenofovir disoproxil (KM-tenofovir disoproxil).
Danish: n De viste tal er kumulative procenter baseret på en Kaplan Meier-analyse, som ekskluderer data indsamlet efter tillæg af emtricitabin til open-label tenofovirdisoproxil (KM-tenofovirdisoproxil).
English: Co-administration of tenofovir disoproxil and didanosine is not recommended as it results in a 40-60% increase in systemic exposure to didanosine that may increase the risk of didanosine-related adverse reactions (see section 4.5).
Danish: Samtidig administration af tenofovirdisoproxil og didanosin anbefales ikke, da det resulterer i en stigning i systemisk eksponering for didanosin på 40-60 %, hvilket kan øge risikoen for didanosinrelaterede bivirkninger (se pkt.
English: The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease.
Danish: Til de mange risikofaktorer for udvikling af denne sygdom hører blandt andre: Varigheden af kombinationsbehandlingen, anvendelse af kortikosteroider, alkoholforbrug, alvorligt nedsat immunforsvar, samt (over)vægt (højere Body Mass Index (BMI)).
English: Adefovir dipivoxil 10 mg n = 125
Danish: 10 mg adefovirdipivoxil n = 125
English: Tenofovir disoproxil Metabolism and nutrition disorders: Very common:
Danish: Tenofovirdisoproxil Metabolisme og ernæring:
English: The following side effects are rare (may affect up to 1 in 1,000 people):
Danish: Følgende bivirkninger er sjældne (kan opstå hos op til 1 ud af 1.000 personer):
English: By intent to treat analysis (missing data and switch in antiretroviral therapy (ART) considered as failure), the proportion of patients with HIV-1 RNA below 400 copies/ml and 50 copies/ml at 48 weeks of treatment was 80% and 76% respectively in the tenofovir disoproxil 245 mg arm, compared to 84% and 80% in the stavudine arm. At 144 weeks, the proportion of patients with HIV-1 RNA below 400 copies/ml and 50 copies/ml was 71% and 68% respectively in the tenofovir disoproxil 245 mg arm, compared to 64% and 63% in the stavudine arm.
Danish: Ved behandlingsintentionsanalyse (manglende data og skift i antiretroviral behandling (ART) blev betragtet som svigt) var procentdelen af patienter med hiv 1-RNA under 400 kopier/ml og 50 kopier/ml i uge 48 af behandlingen henholdsvis 80 % og 76 % i 245 mg tenofovirdisoproxil behandlingsarmen, sammenlignet med 84 % og 80 % i stavudin behandlingsarmen.
English: Co-administration of tenofovir disoproxil with ledipasvir/sofosbuvir, sofosbuvir/velpatasvir or sofosbuvir/velpatasvir/voxilaprevir has been shown to increase plasma concentrations of tenofovir, especially when used together with an HIV regimen containing tenofovir disoproxil and a pharmacokinetic enhancer (ritonavir or cobicistat).
Danish: Brug sammen med visse antivirale lægemidler mod hepatitis C Det er vist, at samtidig administration af tenofovirdisoproxil og ledipasvir/sofosbuvir, sofosbuvir/velpatasvir eller sofosbuvir/velpatasvir/voxilaprevir øger plasmakoncentrationen af tenofovir, især ved brug af et hiv-regime, der indeholder tenofovirdisoproxil og en farmakokinetisk booster (ritonavir eller cobicistat).
English: Tenofovir disoproxil Zentiva contains lactose monohydrate.
Danish: Tenofovir disoproxil Zentiva indeholder lactosemonohydrat.
English: Emtricitabine 200 mg/ tenofovir disoproxil 245 mg (n = 45)
Danish: 200 mg emtricitabin/ 245 mg tenofovirdisoproxil (n = 45)
English: Co-administration of tenofovir disoproxil and didanosine is not recommended (see section
Danish: Samtidig administration af tenofovirdisoproxil og didanosin kan ikke anbefales (se pkt.
English: There are uncertainties associated with the long-term effects of bone and renal toxicity.
Danish: Påvirkning af nyrer og knogler hos den pædiatriske population Der er usikkerheder i forbindelse med virkningen af langvarig behandling på knogle- og nyretoksicitet.
English: *p-value versus adefovir dipivoxil < 0.05, a Complete response defined as HBV DNA levels < 400 copies/ml and Knodell necroinflammatory score improvement of at least 2 points without worsening in Knodell fibrosis, b Knodell necroinflammatory score improvement of at least 2 points without worsening in Knodell fibrosis, c Median change from baseline HBV DNA merely reflects the difference between baseline HBV DNA and the limit of detection (LOD) of the assay, d The population used for analysis of ALT normalisation included only patients with ALT above ULN at baseline.
Danish: * p-værdi versus adefovirdipivoxil < 0,05. a Komplet respons defineret som HBV-DNA-niveauer < 400 kopier/ml og en forbedring af Knodells nekroinflammatoriske score på mindst 2 point uden forværring af Knodells fibrosescore.
English: Look out for signs of inflammation or infection soon after you start taking Tenofovir disoproxil Zentiva.
Danish: Hold øje med tegn på betændelse eller infektion i tiden lige efter, du begynder at tage
English: If renal abnormalities are suspected or detected then consultation with a nephrologist should be obtained to consider interruption of tenofovir disoproxil treatment.
Danish: Hvis der er mistanke om nyreabnormiteter, eller disse påvises, skal konsultation med en nefrolog foretages for at overveje at seponere behandlingen med tenofovirdisoproxil.
English: Acute exacerbation of hepatitis has been reported in patients on treatment as well as in patients who have discontinued hepatitis B therapy (see section 4.4).
Danish: Der er rapporteret akut hepatitis-eksacerbationer, både under behandling og efter seponering af hepatitis B-behandling (se pkt.
English: Tenofovir disoproxil Zentiva should not be administered concomitantly with adefovir dipivoxil.
Danish: Tenofovir disoproxil Zentiva bør ikke tages samtidigt med adefovirdipivoxil.
English: Co-administration of tenofovir disoproxil and didanosine results in a 40-60% increase in systemic exposure to didanosine that may increase the risk for didanosine-related adverse reactions.
Danish: Samtidig administration af tenofovirdisoproxil og didanosin resulterer i en 4060 % stigning i systemisk eksponering for didanosin, hvilket kan øge risikoen for didanosinrelaterede bivirkninger.
English: If overdose occurs the patient must be monitored for evidence of toxicity (see sections 4.8 and 5.3), and standard supportive treatment applied as necessary.
Danish: Såfremt der forekommer overdosering, skal patienten monitoreres for tegn på toksicitet (se pkt.
English: Lopinavir/Ritonavir (400 mg b.i.d./100 mg b.i.d.)
Danish: Lopinavir/ritonavir (400 b.i.d./100 b.i.d./245 q.d.)
English: If you feel dizzy while taking Tenofovir disoproxil Zentiva, do not drive or ride a bicycle and do not use any tools or machines.
Danish: Kør ikke bil eller motorcykel, lad være med at cykle og lad være med at arbejde med værktøj eller maskiner, hvis du bliver svimmel, når du tager Tenofovir disoproxil Zentiva.
English: Rarely, pancreatitis and lactic acidosis, sometimes fatal, have been reported (see section 4.4).
Danish: Der er rapporteret sjældne tilfælde af pancreatitis og laktatacidose, og nogle af disse tilfælde var letale (se pkt.
English: Co-administration of tenofovir disoproxil and didanosine results in a 40 - 60% increase in systemic exposure to didanosine that may increase the risk of didanosine-related adverse reactions (see section 4.5).
Danish: Samtidig administration af tenofovirdisoproxil og didanosin resulterer i en 40-60 % stigning i systemisk eksponering for didanosin, hvilket kan øge risikoen for didanosin-relaterede bivirkninger (se pkt.
English: Bottle label and outer carton
Danish: Etiket til tabletbeholder og ydre pakning
English: Response to treatment with tenofovir disoproxil was comparable in treatment-naïve and treatmentexperienced subjects with 76% (38/50) of treatment-naïve and 80% (8/10) of treatment-experienced subjects achieving HBV DNA < 400 copies/ml (69 IU/ml) at Week 48.
Danish: Behandlingsresponset med tenofovirdisoproxil var sammenligneligt hos behandlingsnaive og behandlingserfarne forsøgspersoner, hvor 76 % (38/50) behandlingsnaive og 80 % (8/10)
English: Administration of 245 mg tenofovir disoproxil every 48 hours can be used based on modelling of single-dose pharmacokinetic data in HIV-negative and non-HBV infected subjects with varying degrees of renal impairment, including end-stage renal disease requiring haemodialysis, but has not been confirmed in clinical studies.
Danish: Dette er baseret på modellering af farmakokinetiske data for enkeltdosis hos hiv-negative patienter eller patienter uden HBV-infektion men med forskellige grader af nedsat nyrefunktion, herunder nyresygdom i slutstadiet, hvor det er nødvendigt med dialyse, og er ikke blevet bekræftet i kliniske studier.
English: The following side effects are uncommon (may affect up to 1 in 100 people):
Danish: Følgende bivirkninger er ikke almindelige (kan opstå hos op til 1 ud af 100 personer):
English: Musculoskeletal and connective tissue disorders: Uncommon:
Danish: Tenofovirdisoproxil Knogler, led, muskler og bindevæv: Ikke almindelig:
English: Titanium dioxide Triacetin
Danish: Titandioxid
English: Renally eliminated medicinal products
Danish: Lægemidler, som udskilles gennem nyrerne
English: Severe renal impairment: 245 mg tenofovir disoproxil may be administered every 72 - 96 hours (dosing twice a week).
Danish: Svært nedsat nyrefunktion: 245 mg tenofovirdisoproxil kan administreres hver 72.
English: • pancreas problems.
Danish: • problemer med bugspytkirtlen
English: Tenofovir disoproxil 245 mg n = 176
Danish: 245 mg tenofovirdisoproxil n = 176
English: Whole body BMD mean % increase
Danish: Gennemsnitlig stigning (%) i BMD for hele kroppen
English: Lumbar spine mean (SD) change from baseline BMD Z-scorea NA
Danish: Gennemsnitlig (SD) BMD Zresultata for columna lumbalis Gennemsnitlig (SD) ændring i BMD Z-resultata for columna lumbalis fra baseline
English: o 48 weeks of double-blind tenofovir disoproxil followed by 336 weeks open-label.
Danish: o 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 336 uger open-label.
English: e 48 weeks of double-blind tenofovir disoproxil followed by 96 weeks open-label.
Danish: e 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 96 uger open-label.
English: Bone Mineral Density (BMD) data from Study GS-US-174-0115 are summarized in Table 8: Table 8: Bone Mineral Density Evaluation at Baseline, Week 72 and 192
Danish: Data vedrørende knoglemineraltæthed (BMD) fra studiet GS-US-174-0115 er opsummeret i tabel 8:
English: Whole body mean (SD) BMD Z-scorea
Danish: Gennemsnitlig (SD) BMD Z-resultata for hele kroppen
English: The mean rate of lumbar spine bone gain at week 48 was similar between the tenofovir disoproxil treatment group and the stavudine or zidovudine treatment group.
Danish: var sammenlignelig mellem behandlingsgruppen med tenofovirdisoproxil og behandlingsgruppen med stavudin eller zidovudin.
English: Lumbar spine BMD at least 4% decrease
Danish: Mindst 4 % fald i BMD for columna lumbalis
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains tenofovir disoproxil phosphate (equivalent to 245 mg of tenofovir disoproxil).
Danish: Hver filmovertrukket tablet indeholder tenofovirdisoproxilphosphat (svarende til 245 mg tenofovirdisoproxil).
English: At week 72, 96% (27/28) of immuneactive patients (HBV DNA ≥ 105 copies/ml, serum ALT > 1.5 x ULN) in the tenofovir disoproxil treatment group and 0% (0/32) of patients in the placebo group had HBV DNA < 400 copies/ml.
Danish: kopier/ml, serum-ALAT > 1,5 x ULN) i gruppen, der blev behandlet med tenofovirdisoproxil, og 0 % (0/32) af patienterne i placebogruppen HBV-DNA < 400 kopier/ml.
English: As Tenofovir disoproxil Zentiva may cause renal damage monitoring of renal function is recommended (see sections 4.4 and 4.8 Summary of the safety profile).
Danish: Da Tenofovir disoproxil Zentiva kan foråsage nyreskader, anbefales monitorering af nyrefunktionen (se pkt.
English: c 48 weeks double-blind tenofovir disoproxil followed by up to 192 weeks open-label.
Danish: c 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af op til 192 uger open-label.
English: Hepatic impairment No dose adjustment is required in patients with hepatic impairment (see sections 4.4 and 5.2).
Danish: Nedsat leverfunktion Justering af dosis er ikke nødvendig hos patienter med nedsat leverfunktion (se pkt.
English: How to take Tenofovir disoproxil Zentiva
Danish: Sådan skal du tage Tenofovir disoproxil Zentiva
English: The following side effects are common (may affect up to 1 in 10 people):
Danish: Følgende bivirkninger er almindelige (kan opstå hos op til 1 ud af 10 personer):
English: p 48 weeks of double-blind adefovir dipivoxil followed by 336 weeks open-label tenofovir disoproxil.
Danish: p 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 336 uger open-label tenofovirdisoproxil.
English: b 48 weeks of double-blind tenofovir disoproxil followed by 48 weeks open-label.
Danish: b 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 48 uger open-label.
English: Voxilaprevir: AUC: ↑ 143% Cmax:↑ 72% Cmin: ↑ 300%
Danish: AUC: ↑ 143 % Cmax:↑ 72 % Cmin: ↑ 300 %
English: • pain in the tummy (abdomen) caused by inflammation of the pancreas, • damage to kidney tubule cells.
Danish: • beskadigelse af celler i nyrerne (de tubulære celler)
English: The increased exposure of tenofovir could potentiate tenofovir associated adverse events, including renal disorders.
Danish: Den forøgede tenofovir-eksponering kan medføre forstærkede bivirkninger af tenofovirdisoproxil, herunder nyrerelaterede bivirkninger.
English: In patients with severe renal impairment (creatinine clearance < 30 ml/min) and in patients who require haemodialysis use of tenofovir disoproxil is not recommended.
Danish: Det frarådes at bruge tenofovirdisoproxil hos patienter med svært nedsat nyrefunktion (kreatininclearance < 30 ml/min), og hos patienter med behov for hæmodialyse.
English: Bone effects
Danish: Påvirkning af knogler
English: g 48 weeks of double-blind tenofovir disoproxil followed by 144 weeks open-label.
Danish: g 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 144 uger open-label.
English: BATCH NUMBER
Danish: FREMSTILLERENS BATCHNUMMER Lot:
English: In studies GS-US-174-0102 and GS-US-174-0103, after receiving double-blind treatment for 48 weeks (either tenofovir disoproxil 245 mg or adefovir dipivoxil 10 mg), patients rolled over with no interruption in treatment to open-label tenofovir disoproxil.
Danish: I studierne GS-US-174-0102 og GS-US-174-0103 skiftede patienterne uden behandlingsafbrydelse til open-label-behandling med tenofovirdisoproxil efter at have fået dobbeltblind-behandling i 48 uger
English: Then mix the powder with about 100 ml (half a glass) of water, orange juice or grape juice and drink immediately.
Danish: Hvis du har særlige problemer med at synke, kan du knuse tabletten med spidsen af en ske og opløse den i ca. 100 ml (et halvt glas) vand, appelsinjuice eller druesaft.
English: Adefovir dipivoxil 10 mg roll over to tenofovir disoproxil 245 mg n = 125
Danish: 10 mg adefovirdipivoxil skift til 245 mg tenofovirdisoproxil n = 125
English: f 48 weeks of double-blind adefovir dipivoxil followed by 96 weeks open-label tenofovir disoproxil .
Danish: f 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 96 uger open-label tenofovirdisoproxil.
English: Serology (%)HBeAg loss/seroconversionHBsAg loss/seroconversion n/a n/a
Danish: Serologi (%) Tab af HBeAg/ serokonversion Tab af HBsAg/ serokonversion g g l l l g g l l l a
English: Tenofovir disoproxiltenofovir disoproxil
Danish: Tenofovirdi soproxiltenofovirdis oproxil
English: c 48 weeks of double-blind adefovir dipivoxil followed by 48 weeks open-label tenofovir disoproxil .
Danish: c 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 48 uger open-label tenofovirdisoproxil.
English: Tenofovir disoproxil 245 mg n = 250
Danish: 245 mg tenofovirdisoproxil n = 250
English: l 48 weeks of double-blind tenofovir disoproxil followed by 240 weeks open-label.
Danish: 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 240 uger open-label.
English: The safety of tenofovir disoproxil when used with sofosbuvir/velpatasvir/voxil aprevir and a pharmacokinetic enhancer (e.g. ritonavir or cobicistat) has not been established.
Danish: Sikkerheden af tenofovirdisoproxil sammen med sofosbuvir/velpatasvir/voxil aprevir og en farmakokinetisk booster (f.eks. ritonavir eller cobicistat) er ikke klarlagt.
English: What Tenofovir disoproxil Zentiva is and what it is used for What you need to know before you take Tenofovir disoproxil Zentiva How to take Tenofovir disoproxil Zentiva Possible side effects
Danish: Det skal du vide, før du begynder at tage Tenofovir disoproxil Zentiva Sådan skal du tage Tenofovir disoproxil Zentiva Bivirkninger
English: NAME OF THE MEDICINAL PRODUCT Tenofovir disoproxil Zentiva 245 mg film-coated tablets Tenofovir disoproxil
Danish: Tenofovir disoproxil Zentiva 245 mg filmovertrukne tabletter Tenofovirdisoproxil
English: AUC: ↔ Cmax: ↑ 47%
Danish: AUC: ↔ Cmax: ↑ 47 % Cmin: ↑ 47 %
English: Didanosine Co-administration of tenofovir disoproxil and didanosine is not recommended (see section 4.4 and Table 1).
Danish: Didanosin Samtidig administration af tenofovirdisoproxil og didanosin anbefales ikke (se pkt.
English: Adefovir dipivoxil 10 mg roll over to tenofovir disoproxil 245 mg n = 90
Danish: 10 mg adefovirdipivoxil skift til 245 mg tenofovirdisoproxil n = 90
English: No data are available to make dose recommendations (see sections 4.2 and 4.4).
Danish: Der foreligger ingen data for dosisanbefalinger (se pkt.
English: asthenia
Danish: Behandling
English: medicines which are no longer fully effective due to development of resistance, or have caused side effects.
Danish: • unge i alderen 12 til under 18 år, som allerede er blevet behandlet med anden hiv-medicin, der ikke længere er helt effektivt på grund af udvikling af resistens, eller der forårsagede bivirkninger.
English: • stomach pain,
Danish: • hovedpine • mavesmerter
English: Lumbar spine BMD at least 6% decreaseb
Danish: Mindst 6 % fald i BMD for columna lumbalis b
English: In adult patients with decompensated liver disease or cirrhosis, treatment cessation is not recommended.
Danish: Seponering af behandlingen frarådes hos voksne patienter med dekompenseret leversygdom eller levercirrose.
English: The increased exposure of tenofovir could potentiate adverse reactions associated with tenofovir disoproxil, including renal disorders.
Danish: Den forøgede tenofovir-eksponering kan forstærke effekten af bivirkninger ved tenofovirdisoproxil, herunder nyresygdomme.
English: Lumbar spine mean (SD) BMD Z-scorea
Danish: Gennemsnitlig (SD) BMD Z-resultata for columna lumbalis
English: Sofosbuvir: AUC: ↓ 27%
Danish: Sofosbuvir: AUC: ↔ Cmax: ↓ 19 %
English: h 48 weeks of double-blind tenofovir disoproxil followed by 144 weeks open-label.
Danish: h 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 144 uger open-label.
English: Whole body mean (SD) change from baseline
Danish: Gennemsnitlig (SD) ændring i BMD Zresultata for hele kroppen fra baseline
English: fatigue
Danish: laktatacidose
English: j 48 weeks of double-blind tenofovir disoproxil followed by 192 weeks open-label.
Danish: j 48 uger dobbeltblind tenofovirdisoproxil, efterfulgt af 192 uger open-label.
English: i 48 weeks of double-blind adefovir dipivoxil followed by 144 weeks open-label tenofovir disoproxil .
Danish: 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 144 uger open-label tenofovirdisoproxil.
English: • flatulence.
Danish: • afgang af tarmluft (flatulens)
English: n 48 weeks of double-blind adefovir dipivoxil followed by 240 weeks open-label tenofovir disoproxil .
Danish: 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 240 uger open-label tenofovirdisoproxil.
English: diarrhoea, vomiting, nausea
Danish: Meget almindelig: diarré, opkastning, kvalme Almindelig:
English: Tenofovir disoproxil 245 mg (n = 45)
Danish: 245 mg tenofovirdisoproxil (n = 45)
English: Darunavir/Ritonavir (300 mg/100 mg b.i.d.)
Danish: Darunavir/ritonavir (300/100 b.i.d./245 q.d.)
English: hypokalaemia1
Danish: hypokaliæmi
English: + Emtricitabine/Rilpivirine/ Tenofovir disoproxil (200 mg/25 mg/245 mg q.d.)
Danish: + Emtricitabin/rilpivirin/tenofovi rdisoproxil (200 mg/25 mg/245 mg q.d.)
English: d 48 weeks double-blind adefovir dipivoxil followed by up to 192 weeks open-label tenofovir disoproxil .
Danish: 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af op til 192 uger open-label tenofovirdisoproxil.
English: Gastrointestinal disorders: Very common:
Danish: Meget almindelig: svimmelhed Almindelig:
English: Mean change from baseline in CPT score
Danish: resultata for columna lumbalis fra baseline NA
English: - foscarnet, ganciclovir, or cidofovir (for viral infection) - interleukin-2 (to treat cancer) - adefovir dipivoxil (for HBV) - tacrolimus (for suppression of the immune system) - non-steroidal anti-inflammatory drugs (NSAIDs, to relieve bone or muscle pains)
Danish: − foscarnet, ganciclovir eller cidofovir (mod virusinfektion)
English: + Efavirenz/Emtricitabine/ Tenofovir disoproxil (600 mg/200 mg/245 mg q.d.)
Danish: + Efavirenz/emtricitabin/ tenofovirdisoproxil (600 mg/200 mg/245 mg q.d.)
English: Management
Danish: Fremstiller
English: k 48 weeks of double-blind adefovir dipivoxil followed by 192 weeks open-label tenofovir disoproxil .
Danish: j 48 uger dobbeltblind adefovirdipivoxil, efterfulgt af 192 uger open-label tenofovirdisoproxil.
English: • drowsiness,
Danish: • svimmelhed